Targeting the PI 3K signaling pathway in KRAS mutant colon cancer-Reference-Cited by-同舟云学术

Targeting the PI 3K signaling pathway in KRAS mutant colon cancer

Published:2015-12-29 Issue:2 Volume:5 Page:248-255
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Hong Suntaek¹,Kim SoYoung²³,Kim Hye Youn¹,Kang Myunghee⁴,Jang Ho Hee¹³,Lee Won‐Suk¹²³

Affiliation:

1. Lee Gil Ya Cancer and Diabetes Institute Gachon University Incheon Korea

2. Department of Surgery Gil Medical Center Gachon University Incheon Korea

3. Gachon Medical Research Institute Gil Medical Center Incheon Korea

4. Department of Pathology Gil Medical Center Gachon University Incheon Korea

Funder

Gachon University

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.591

Reference20 articles.

1. CALGB/SWOG 80405: Phase III trial of irinotecan/5‐FU/leucovorin (FOLFIRI) or oxaliplatin/5‐FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild‐type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC);Venook A. P.;ASCO Meet Abstr.,2014

2. Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway

3. Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review

4. Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

5. Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Colorectal cancer: understanding of disease;Colorectal Cancer;2024

2. Targeted nanodelivery of siRNA against KRAS G12D inhibits pancreatic cancer;Acta Biomaterialia;2023-09

3. Shifting KRAS hotspot mutations inhibition paradigm in colorectal cancer;2023-08-13

4. Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibition;JCI Insight;2023-05-08

5. The potential effect of Schisandrin‐B combination with panitumumab in wild‐type and mutant colorectal cancer cell lines: Role of apoptosis and autophagy;Journal of Biochemical and Molecular Toxicology;2023-02-19